Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

MBrace specializes in developing novel cancer treatments based on the SPARTA technology, a robust antibody discovery methodology pioneered by the company's founders. The SPARTA technology addresses key challenges in antibody development, enabling the rapid translation of human antibodies into clinical applications. MBrace's focus includes the development of Antibody-Drug Conjugates (ADCs) targeting two innovative cancer targ...
MBrace specializes in developing novel cancer treatments based on the SPARTA technology, a robust antibody discovery methodology pioneered by the company's founders. The SPARTA technology addresses key challenges in antibody development, enabling the rapid translation of human antibodies into clinical applications. MBrace's focus includes the development of Antibody-Drug Conjugates (ADCs) targeting two innovative cancer targets using human antibodies selected through the SPARTA methodology.

List your booth number for exhibitions, ask us